Back
Severn Trent Plc Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Sell
24
STRNY
Severn Trent Plc
Last Price:
$37.25
Seasonality Move:
-0.03%
Sell
44
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$112.11
Seasonality Move:
-13.08%
Sell
24
Severn Trent Plc (STRNY)
is a Sell
Is Severn Trent Plc a Buy, Sell or Hold?
-
The current Severn Trent Plc [STRNY] share price is $37.51. The Score for STRNY is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
STRNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Sell
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $111.73. The Score for RYTM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
STRNY Stock Price Chart
What is Severn Trent Plc's stock price today?
-
The Severn Trent Plc share price today is $37.51Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STRNY is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $111.73Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight buying pressure.
STRNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.31 | Buy |
| Relative Strength Index (14 RSI): | 52.9 | Buy |
| Chaikin Money Flow: | -8021 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.56 - 38.02) | Buy |
| Bollinger Bands (100): | (35.19 - 37.45) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.8 | Buy |
| Relative Strength Index (14 RSI): | 56.8 | Buy |
| Chaikin Money Flow: | 32783 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (100.63 - 111.03) | Buy |
| Bollinger Bands (100): | (95.29 - 108.53) | Buy |
STRNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.04 | Buy |
| 20-day SMA: | 37.47 | Buy |
| 50-day SMA: | 37.26 | Buy |
| 200-day SMA: | 35.88 | Buy |
| 8-day EMA: | 14.84 | Buy |
| 20-day EMA: | 6.82 | Buy |
| 50-day EMA: | 2.89 | Buy |
| 200-day EMA: | 0.74 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.65 | Buy |
| 20-day SMA: | 107.3 | Buy |
| 50-day SMA: | 106.17 | Buy |
| 200-day SMA: | 82.91 | Buy |
| 8-day EMA: | 44.16 | Buy |
| 20-day EMA: | 20.28 | Buy |
| 50-day EMA: | 8.6 | Buy |
| 200-day EMA: | 2.21 | Buy |
Severn Trent Plc Earnings Growth & STRNY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.
Severn Trent Plc Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||